Article
Considering B7-CD28 as a family through sequence and structure
17 Jun 2019
Abstract excerpt
With the emergence of immuno-oncology, new therapeutic agents that modulate immune activation and regulation are being used to treat cancer patients with durable response. It is well known that following T-cell receptor (TCR) activation, many co-receptors can augment or suppress the TCR signal, and therapeutically targeting these co-receptors has proven effective. The B7-CD28 family is comprised of such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
